Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value
Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value GlobeNewswire November 11, 2025 Confirms Receipt of Unsolicited Indication of Interest and Director Nominations from Lynx1 Master Fund LP No Stockholder Action Required at This Time BURLINGTON, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) — Neuphoria Therapeutics Inc. (“Neuphoria” or the “Company”) (Nasdaq: NEUP), a clinical-stage […]